Supriya Lifescience Ltd.
SUPRIYA Share PricePharmaceuticals & Drugs
₹652.15
0.6 (0.1%)
As on September 8, 2025
Exchange Scrips: BSE543434NSESUPRIYAISININE07RO01027
Market Cap ₹ 5,267 Cr
P/E Ratio 44.07
Dividend Yield 0.06 %
Performance
Market performance
Open651.8
High661.95
Volumes63,917
Prev652.15
Low649.05
As on2025-09-08
Historical performance
1 Year High842
3 Year High842
5 Year High842
1 Year Low511.4
3 Year Low170.15
5 Year Low170.15
Fundamentals
Company Valuation
Market Cap (₹Cr)
5,267
Face Value (₹)
2
P/E Ratio
44.07
Dividend Yield
0.06 %
Investment Returns
1 Year
9.6%
3 Years
87.9%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 655.83 | Bearish |
| 10-DMA | 657.02 | Bearish |
| 20-DMA | 662.59 | Bearish |
| 50-DMA | 682.12 | Bearish |
| 100-DMA | 687.22 | Bearish |
| 200-DMA | 697.38 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 6 | 6 | 6 | 6 | 6 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 6 | 6 | 6 | 6 | 6 |
| Public Investors | 91922 | 91045 | 89388 | 85322 | 89615 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 44.07.
- 3Y Stock Price CAGR of the stock is 23.3.
- The stock has a beta of 1.9.
- In the last financial year, the company had an EBITDA of ₹1866 Million.
- The company generated revenue of ₹5704 Million in the previous financial year.
Supriya Lifescience Ltd.
652.150.6 (0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1072086.1
No. of Shares: 1644 (Approx)
Performance:7.2%
P/L: ₹72086.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent